What Happened?
Thousand Oaks, CA-based Amgen Promoted Jerry Gross as Head of Technology Innovation
About the Company
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people`s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world`s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
About the Person
Jeremy Gross is Chief Technology Officer at Medvantx. Previously, Jeremy held various senior IT leadership roles in the industry.
Info Source
News
Short Profile